Russell P. Bowler

National Jewish Health

Papers

1

Total Citations

17

H-Index

1

About

Dr. Russell P. Bowler is a leading pulmonary researcher whose work bridges environmental toxicology and respiratory medicine. His investigations focus on how inhaled substances—from combustible cigarettes to electronic nicotine delivery systems—impact lung health at the particle level. In a landmark 2023 study, Dr. Bowler demonstrated that menthol-flavored e-liquids generate significantly more inhaled micro- and sub-micron particles than non-flavored alternatives, and that these particles are associated with measurable declines in lung function among smokers who also use combustible cigarettes. This finding, already cited 17 times, challenges assumptions about the safety of flavoring agents in vaping products and has immediate implications for public health policy. Dr. Bowler’s work is distinguished by its translational approach, combining rigorous aerosol physics with clinical spirometry to reveal how seemingly minor product modifications can have outsized biological effects. His research has been instrumental in shaping regulatory discussions around e-cigarette flavor bans, and he continues to be a sought-after voice on the respiratory consequences of emerging nicotine delivery technologies.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Electronic cigarette menthol flavoring is associated with increased inhaled micro and sub-micron particles and worse lung function in combustion cigarette smokers
17 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: National Jewish Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago